Successful small-incision lenticule extraction for myopia

Article

Small-incision lenticule extraction for moderate to high myopia provides high rates of patient satisfaction, refractive predictability and is a safe procedure.

Small-incision lenticule extraction for moderate to high myopia provides high rates of patient satisfaction, refractive predictability and is a safe procedure.

Dr Anders Vestergaard et al., Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark, conducted a prospective clinical study on 144 patients with moderate to high myopia.

Small-incision lenticule extraction was performed with a femtosecond laser and manually extracted without flap creation. Each patient was treated and assessed for three months. One randomly selected eye of each patient was used for the statistical analyses.

Mean preoperative spherical equivalent was −7.18 D ± 1.57. In 40% of eyes with emmetropia as target refraction the uncorrected distance visual acuity was 0.1 logMAR or less one day postoperatively. This increased to 73% at three months postoperatively.

Mean corrected distance visual acuity (CDVA) significantly improved from -0.01 preoperatively to -0.03 three months postoperatively. Of the eyes studied, six lost one line of CDVA after three months and none of the eyes lost two lines or more of CDVA.

Achieved mean refraction was −0.09 ± 0.45 D from the attempted refraction. Out of the eyes included, 77% were within ±0.50 D and 95% were within ±1.00 D. As for patient satisfaction, 95% of the patients recommended the procedure to others.

To view the abstract visit the

Journal of Cataract and Refractive Surgery.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.